Publication list
2021
Bereczky, Z.,
Gindele, R.,
Fiatal, S.,
Speker, M.,
Miklós, T.,
Balogh, L.,
Mezei, Z.,
Szabó, Z.,
Ádány, R.:
Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.
Front. Cardiovasc. Med. 7 1-15, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Morena-Barrio, M.,
Gindele, R.,
Bravo-Pérez, C.,
Ilonczai, P.,
Zuazu, I.,
Speker, M.,
Oláh, Z.,
Rodríguez-Sevilla, J.,
Entrena, L.,
Infante, M.,
Morena-Barrio, B.,
García, J.,
Schlammadinger, Á.,
Cifuentes-Riquelme, R.,
Mora, -.,
Miñano, A.,
Padilla, J.,
Vicente, V.,
Corral, J.,
Bereczky, Z.:
High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: description of a new syndrome.
Am. J. Hematol. 96 (11), 1363-1373, 2021.
2018
Katona, É.,
Kissné Bogáti, R.,
Miklós, T.,
Gindele, R.,
Speker, M.,
Fedoriska, V.,
Orosz, A.,
Mezei, Z.,
Bereczky, Z.:
ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.
Gindele, R.,
Colombo, R.,
Szabó, Z.,
Speker, M.,
Mezei, Z.,
Balogh, L.,
Katona, É.,
Bagoly, Z.,
Fiatal, S.,
Bereczky, Z.:
Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.
Katona, É.,
Kissné Bogáti, R.,
Miklós, T.,
Gindele, R.,
Speker, M.,
Fedoriska, V.,
Orosz, A.,
Mezei, Z.,
Bereczky, Z.:
The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2 324-324, 2018.
2016
Bereczky, Z.,
Speker, M.,
Gindele, R.,
Szabó, Z.,
Oláh, Z.,
Pfliegler, G.,
Kerényi, A.,
Boda, Z.:
Diagnostic issues in antithrombin, protein C and protein S deficiency in the hungarian population: experience of a large thrombosis laboratory.
J. Throm. Haemost. 14 (Suppl.), 98, 2016.
Gindele, R.,
Oláh, Z.,
Ilonczai, P.,
Speker, M.,
Udvari, Á.,
Selmeczi, A.,
Pfliegler, G.,
Marján, E.,
Kovács, B.,
Boda, Z.,
Muszbek, L.,
Bereczky, Z.:
Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.
J. Thromb. Haemost. 14 (4), 704-715, 2016.
Journal metrics:
D1 Hematology
D1 Medicine (miscellaneous)
updated: 2024-11-10, 01:45
